DOI QR코드

DOI QR Code

How Our Practice of Histopathology, Especially Tumour Pathology has Changed in the Last Two Decades: Reflections from a Major Referral Center in Pakistan

  • Ahmad, Zubair (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Idrees, Romana (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Fatima, Saira (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Arshad, Huma (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Din, Nasir-Ud (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Memon, Aisha (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Minhas, Khurram (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Ahmed, Arsalan (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Fatima, Syeda Samia (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Arif, Muhammad (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Ahmed, Rashida (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Haroon, Saroona (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Pervez, Shahid (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Hassan, Sheema (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital) ;
  • Kayani, Naila (Section of Histopathology, Department of Pathology and Microbiology, Aga Khan University Hospital)
  • 발행 : 2014.05.15

초록

Continued advances in the field of histo pathology (and cyto pathology) over the past two decades have resulted in dramatic changes in the manner in which these disciplines are now practiced. This is especially true in the setting of a large university hospital where the role of pathologists as clinicians (diagnosticians), undergraduate and postgraduate educators, and researchers has evolved considerably. The world around us has changed significantly during this period bringing about a considerable change in our lifestyles and the way we live. This is the world of the internet and the world-wide web, the world of Google and Wikipedia, of Youtube and Facebook where anyone can obtain any information one desires at the push of a button. The practice of histo (and cyto) pathology has also evolved in line with these changes. For those practicing this discipline in a poor, developing country these changes have been breathtaking. This is an attempt to document these changes as experienced by histo (and cyto) pathologists practicing in the biggest center for Histopathology in Pakistan, a developing country in South Asia with a large (180 million) and ever growing population. The Section of Histopathology, Department of Pathology and Microbiology at the Aga Khan University Hospital (AKUH) in Karachi, Pakistan's largest city has since its inception in the mid-1980s transformed the way histopathology is practiced in Pakistan by incorporating modern methods and rescuing histopathology in Pakistan from the primitive and outdated groove in which it was stuck for decades. It set histopathology in Pakistan firmly on the path of modernity and change which are essential for better patient management and care through accurate and complete diagnosis and more recently prognostic and predictive information as well.

키워드

참고문헌

  1. Abdel-Fatah TM, Powe DG, Hodi Z, et al (2007). High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol, 31, 417-26. https://doi.org/10.1097/01.pas.0000213368.41251.b9
  2. Abenoza P, Lillemoe T (1993). CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol, 15, 429-34. https://doi.org/10.1097/00000372-199310000-00003
  3. Abrahams NA, Ormsby AH, Brainard J (2002). Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology, 41, 35-41. https://doi.org/10.1046/j.1365-2559.2002.01425.x
  4. Acs G, Lawton TJ, Rebbeck TR, et al (2001). Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol, 115, 85-98. https://doi.org/10.1309/FDHX-L92R-BATQ-2GE0
  5. Ahmad Z, Ahsan A, Sheikh U, et al (2007). Post-transplant T-cell type lymphoproliferative disorder. J Coll Physicians Surg Pak, 17, 766-8.
  6. Ahmad Z, Arshad H (2013). Needle biopsy findings in prostatic adenocarcinoma: experience at a tertiary care center in a developing country. Ann Diagn Pathol, 17, 235-8. https://doi.org/10.1016/j.anndiagpath.2012.10.007
  7. Ahmad Z, Arshad H, Hasan SH, et al (2011). CNS neoplasms in Pakistan, a pathological perspective. Asian Pac J Cancer Prev, 12, 317-21.
  8. Ahmad Z, Barakzai MA, Idrees R, et al (2008). Correlation of intra-operative frozen section consultation with the final diagnosis at a referral center in Karachi, Pakistan. Indian J Pathol Microbiol, 51, 469-73. https://doi.org/10.4103/0377-4929.43733
  9. Ahmad Z, Khan R, Barakzai A, et al (2011). Diffuse ganglioneuromatosis of intestine in a 15-year-old girl. BMJ Case Rep, 2011, 4151.
  10. Ahmad Z, Muzaffar S, Khan M, et al (2002). Transitional cell carcinoma of the urinary bladder. a histopathological study. J Pak Med Assoc, 52, 396-8.
  11. Ahmad Z, Qureshi A (2010). Primary signet ring cell carcinoma of gall bladder: report of an extremely rare histological type of primary gall bladder carcinoma. BMJ Case Rep, 2010, 1782.
  12. Ahmad Z, Qureshi A, Khurshid A (2009). The practice of histopathology in a developing country: difficulties and challenges; plus a discussion on the terrible disease burden we carry. J Clin Pathol, 62, 97-101. https://doi.org/10.1136/jcp.2008.061606
  13. Ahmad Z, Yaqoob N, Muzaffar S, et al (2005). Solid and cystic epithelial neoplasm of pancreas with metastasis: report of a highly unusual case. J Pak Med Assoc, 55, 37-9.
  14. Alameda F, Munne A, Baro T, et al (2006). Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study. Ultrastruct Pathol, 30, 193-205. https://doi.org/10.1080/01913120500520911
  15. Ali SZ, Cibas ES (2010). The Bethesda System for reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes. Springer, New York.
  16. Allsbrook WC, Mangold KA, Johnson MH et al (2001a). Interobserver reproducibility of gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol, 32, 74-80. https://doi.org/10.1053/hupa.2001.21134
  17. Allsbrook WC, Mangold KA, Johnson MH et al (2001b). Interobserver reproducibility of gleason grading of prostatic carcinoma: general pathologists. Hum Pathol, 32, 81-8. https://doi.org/10.1053/hupa.2001.21135
  18. Ally MR, Veerappan GR, Maydonovitch CL, et al (2009). Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci, 54, 2617-22. https://doi.org/10.1007/s10620-009-0993-z
  19. Amin MB, Gomez JA, Young RH (1997). Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol, 21, 1057-68. https://doi.org/10.1097/00000478-199709000-00010
  20. Amin MB, Murphy WM, Reuter VE, et al (1997). A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder, Part II. Anat Pathol, 2, 71-110.
  21. Appin CL, Gao J, Chisolm C, et al (2013). Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics. Brain Pathol, 23, 454-61. https://doi.org/10.1111/bpa.12018
  22. Arshad H, Ahmad Z (2012). Histologic findings in biopsies/resection specimens from the small intestine with special emphasis on celiac disease: experience from a developing country in South Asia. Ann Diagn Pathol, 16, 436-40. https://doi.org/10.1016/j.anndiagpath.2012.03.003
  23. Arshad H, Ahmad Z (2013). Overview of benign and malignant prostatic disease in Pakistani patients: a clinical and histopathological perspective. Asian Pac J Cancer Prev, 14, 3005-10. https://doi.org/10.7314/APJCP.2013.14.5.3005
  24. Arshad H, Ahmad Z, Hasan SH (2010). Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev, 11, 1637-40.
  25. Ash JE (1940). Epithelial tumors of bladder. J Urol, 44, 135-45. https://doi.org/10.1016/S0022-5347(17)71253-0
  26. Astler VB, Coller FA (1954). The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg, 139, 846-52. https://doi.org/10.1097/00000658-195406000-00015
  27. Attygalle AD, Chuang SS, Diss TC, et al (2007). Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology, 50, 498-508. https://doi.org/10.1111/j.1365-2559.2007.02632.x
  28. Ayhan A, Taskiran C, Yuce K, et al (2003). The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma. Int J Gynecol Pathol, 22, 71-4. https://doi.org/10.1097/00004347-200301000-00014
  29. Azzopardi JG (1979). Problems in breast pathology. In Bennington JL(ed): Major Problems in Pathology. Vol. 11. Philadelphia, W.B. Saunders.
  30. Balch CM, Buzaid AC, Soong SJ, et al (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol, 19, 3635-48. https://doi.org/10.1200/JCO.2001.19.16.3635
  31. Balch CM, Morton DL, Gershenwald JE, et al (2009). Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol, 60, 872-5. https://doi.org/10.1016/j.jaad.2008.09.067
  32. Balch CM, Murad TM, Soong SJ, et al (1978). A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg, 188, 732-42. https://doi.org/10.1097/00000658-197812000-00004
  33. Balistreri WF, Bezerra JA (2006). Whatever happened to "neonatal hepatitis"? Clin Liver Dis, 10, 27-53. https://doi.org/10.1016/j.cld.2005.10.008
  34. Barron JJ, Cziraky MJ, Weisman T, et al (2009). HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment. Oncologist, 14, 760-8.
  35. Beer TW, Shepherd P, Theaker JM (2000). Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology, 37, 218-23. https://doi.org/10.1046/j.1365-2559.2000.00999.x
  36. Bejarano PA, Nikiforov YE, Swenson ES, et al (2000). Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol, 8, 189-94.
  37. Bell DW, Brannigan BW, Matsuo K, et al (2008). Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res, 14, 4079-84. https://doi.org/10.1158/1078-0432.CCR-07-5030
  38. Bertucci F, Finetti P, Cervera N, et al (2008). How basal are triple-negative breast cancers? Int J Cancer, 123, 236-40. https://doi.org/10.1002/ijc.23518
  39. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al (2005). Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol, 29, 653-9. https://doi.org/10.1097/01.pas.0000157938.95785.da
  40. Biegel JA, Zhou JY, Rorke LB, et al (1999). Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res, 59, 74-9.
  41. Billis A, Guimaraes MS, Freitas LL et al (2008). The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol, 180, 548-52. https://doi.org/10.1016/j.juro.2008.04.018
  42. Bishop JA, Sharma R, Illei PB (2010). Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol, 41, 20-5. https://doi.org/10.1016/j.humpath.2009.06.014
  43. Bloom HJG, Richardson WM (1957). Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11, 359-77. https://doi.org/10.1038/bjc.1957.43
  44. Bordow SB, Norris MD, Haber PS, et al (1998). Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol, 16, 3286-94. https://doi.org/10.1200/JCO.1998.16.10.3286
  45. Bosman FT, Carneiro F, Hruban RH, et al (2010). World Health Organization Classification of Tumor. WHO classification of Tumor of the Digestive System. IARC, Lyon.
  46. Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK, et al (2008). Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med, 132, 993-1007.
  47. Breslow A (1975). Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg, 182, 572-5. https://doi.org/10.1097/00000658-197511000-00007
  48. Bridge JA, Hogendoorn PCW, Mertens F eds (2013). TNM classification of Bone Sarcomas: In Fletcher CDM: WHO Classification of Tumors of Soft tissue and bone. 4th edition, IARC, Lyon, 242.
  49. Brunning RD, Borowitz M, Flandrin G, et al (2001). Precursor B lymphoblastic leukaemia/lymphoblastic lymphoma (Precursor B-cell acute lymphoblastic leukaemia). In Jaffe ES, Harris NL, Stein H, Vardiman JW. WHO Classification of Tumors. Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, 111-4.
  50. Burger PC, Scheithauer BW, Vogel FS (2002). Surgical Pathology of the Nervous System and its coverings. Fourth Edition. Churchill Livingstone, Elsevier.
  51. Burghardt E, Girardi F, Lahousen M, et al (1991). Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer, 67, 1037-45. https://doi.org/10.1002/1097-0142(19910215)67:4<1037::AID-CNCR2820670429>3.0.CO;2-2
  52. Busam KJ, Iversen K, Coplan KA, et al (1998). Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol, 22, 57-63. https://doi.org/10.1097/00000478-199801000-00007
  53. Buttner P, Garbe C, Bertz J, et al (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75, 2499-506. https://doi.org/10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8
  54. Cao W, Goolsby CL, Nelson BP, et al (2008). Instability of immunophenotype in plasma cell myeloma. Am J Clin Pathol, 129, 926-33. https://doi.org/10.1309/8UVF7YQ1D4D4ETQV
  55. Carcingin ML, Steeper T, Zampi G, et al (1985). Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol, 83, 135-58. https://doi.org/10.1093/ajcp/83.2.135
  56. Carr NJ, Sobin LH (2010). Adenocarcinoma of the appendix. In Bosman FT, Carueiro F, Hruban RH, Theise ND, WHO classification of Tumor of the Digestive System. 4th Edition. IARC Lyon, 122-5
  57. Catlona WJ (1995). Surgical management of prostatic cancer: contemporary results with anatomic radical prostatectomy. Cancer, 75, 1903-8. https://doi.org/10.1002/1097-0142(19950401)75:7+<1903::AID-CNCR2820751624>3.0.CO;2-#
  58. Cessna MH, Zhou H, Perkins SL, et al (2001). Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol, 25, 1150-7. https://doi.org/10.1097/00000478-200109000-00005
  59. Chan ACL, Chan JKC (2010). Diffuse large B-cell lymphoma. In Jaffe ES, Harris NL, Vardiman J, Campo E, Arber DA (eds): Hematopathology. Philadelphia, Saunders.
  60. Chan JK, Banks PM, Cleary ML, et al (1995). A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol, 103, 543-60. https://doi.org/10.1093/ajcp/103.5.543
  61. Chan JKC, Quintanilla-Martinez L, Ferry JA, et al (2008). Extranodal NK/T-cell lymphoma, nasal type. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 285-8.
  62. Cheung CC, Ezzat S, Freeman JL, et al (2001). Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol, 14, 338-42. https://doi.org/10.1038/modpathol.3880312
  63. Cho EY, Ahn GH (2001). Immunoexpression of inhibin alpha-subunit in adrenal neoplasms. Appl Immunohistochem Mol Morphol, 9, 222-8.
  64. Cho KR, Shih Ie M (2009). Ovarian cancer. Annu Rev Pathol, 4, 287-313. https://doi.org/10.1146/annurev.pathol.4.110807.092246
  65. Choi H, Almagro UA, McManus JT, et al (1983). Renal oncocytoma. A clinicopathologic study. Cancer, 51, 1887-96. https://doi.org/10.1002/1097-0142(19830515)51:10<1887::AID-CNCR2820511022>3.0.CO;2-B
  66. Choi HS, Anderson PJ (1985). Immunohistochemical diagnosis of olfactory neuroblastoma. J Neuropathol Exp Neurol, 44, 18-31. https://doi.org/10.1097/00005072-198501000-00002
  67. Churg J, Bernstein J, Glassock RJ (1995). Renal disease: classification and atlas of glomerular disease, ed 2. Newyork, Igaku-shoin, 3-21.
  68. Clark WH Jr, From L, Bernardino EA, et al (1969). The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res, 29, 705-27.
  69. Clark WH Jr, Goldman LI, Mastrangelo MJ (1979). Human malignant melanoma. Clinical Oncology Monographs. New York, Grune and Stratton.
  70. Clement PB, Scully RE (1990). Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol, 21, 363-81. https://doi.org/10.1016/0046-8177(90)90198-E
  71. Coindre JM (2006). Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med, 130, 1448-53.
  72. Collins DH, Pugh RC (1964). Classification and frequency of testicular tumours. Br J Urol, 36, 1-11. https://doi.org/10.1111/j.1464-410X.1964.tb09472.x
  73. Collins LC, Schnitt SJ (2008). Papillary lesions of the breast: selected diagnostic and management issues. Histopathology, 52, 20-9.
  74. Colvin RB (2007). Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol, 18, 1046-56. https://doi.org/10.1681/ASN.2007010073
  75. Crespo M, Bosch F, Villamor N, et al (2003). ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med, 348, 1764-75. https://doi.org/10.1056/NEJMoa023143
  76. Crum CP (2003). Symposium part 1: should the bethesda system terminology be used in diagnostic surgical pathology? Point. Int J Gynecol Pathol, 22, 5-12. https://doi.org/10.1097/00004347-200301000-00003
  77. Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents. IARC, Lyon.
  78. Dabbs DJ, Bhargava R, Chivukula M (2007). Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol, 31, 427-37. https://doi.org/10.1097/01.pas.0000213386.63160.3f
  79. Darvishian F, Hummer AJ, Thaler HT, et al (2004). Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol, 28, 1568-78. https://doi.org/10.1097/00000478-200412000-00004
  80. Daumas-Duport C, Scheithauer B, O'Fallon J et al (1988). Grading of astrocytomas. A simple and reproducible method. Cancer, 62, 2152-65. https://doi.org/10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T
  81. De Boer CJ, Schuuring E, Dreef E, et al (1995). Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood, 86, 2715-23.
  82. De Wit NJ, van Muijen GN, Ruiter DJ (2004). Immunohistochemistry in melanocytic proliferative lesions. Histopathology, 44, 517-41. https://doi.org/10.1111/j.1365-2559.2004.01860.x
  83. Delsol G, Al Saati T, Gatter KC, et al (1988). Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol, 130, 59-70.
  84. Delsol G, Campo E, Gascoyne RD (2008). Alk-positive large B-cell lymphoma. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 254-5.
  85. Delsol G, Ralfkiaer E, Stein H, et al (2001). Anaplastic Large Cell Lymphoma. In Jaffe ES, Harris NL, Stein H, Vardiman JW eds. WHO Classification of Tumors. Pathology and genetics of tumors of Haematopoietic and Lymphoid Tissues. IARC press, Lyon, 230-5.
  86. Desmet VJ (1992). What is congenital hepatic fibrosis? Histopathology, 20, 465-77.
  87. DeYoung BR, Swanson PE, Argenyi ZB, et al (1995). CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol, 22, 215-22. https://doi.org/10.1111/j.1600-0560.1995.tb00741.x
  88. Dixon FJ, Moore RA (1952). Tumors of the male sex organs. In Atlas of Tumor Pathology, series 1, section VIII, fascicles 31b and 32, Washington DC, 1952; Armed Forces Institute of Pathology.
  89. Dominguez-Malagon HR, Ordonez NG, Mackay B (1995). Dermatofibrosarcoma protuberans: ultrastructural and immunocytochemical observations. Ultrastruct Pathol, 19, 281-9. https://doi.org/10.3109/01913129509064232
  90. Dong F, Wang C, Farris AB et al (2012). Impact on the clinical outcome of prostate cancer by the 2005 International Society of Urological Pathology modified Gleason grading system. Am J Surg Pathol, 36, 838-43. https://doi.org/10.1097/PAS.0b013e3182486faf
  91. Edges SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
  92. Elisei R, Ugolini C, Viola D, et al (2008). BRAF (V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab, 93, 3943-9. https://doi.org/10.1210/jc.2008-0607
  93. Ellison DW, Dalton J, Kocak M, et al (2011). Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol, 121, 381-96. https://doi.org/10.1007/s00401-011-0800-8
  94. Elston CW, Ellis IO (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-10. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x
  95. Emerson RE, Ulbright TM (2005). The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis. Semin Diagn Pathol, 22, 33-50. https://doi.org/10.1053/j.semdp.2005.11.003
  96. Engel P, Anagnostaki L, Braendstrup O (1992). The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies. Scand J Urol Nephrol, 26, 249-52. https://doi.org/10.3109/00365599209180877
  97. Epstein JI, Amin MB, Reuter VR et al (1998). The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 22, 1435-48. https://doi.org/10.1097/00000478-199812000-00001
  98. Erkilic S, Kocer NE (2005). The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease. Endocr Pathol, 16, 63-6. https://doi.org/10.1385/EP:16:1:063
  99. Esaki M, Matsumoto T, Kobayashi H, et al (2001). Cap polyposis of the colon and rectum: an analysis of endoscopic findings. Endoscopy, 54, 388-91.
  100. Espinosa I, Lee CH, Kim MK, et al (2008). A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol, 32, 210-8. https://doi.org/10.1097/PAS.0b013e3181238cec
  101. Evans HL (1982). Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer, 50, 2170-82. https://doi.org/10.1002/1097-0142(19821115)50:10<2170::AID-CNCR2820501033>3.0.CO;2-K
  102. Evans HL, Ayala AG, Romsdahl MM (1977). Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer, 40, 818-31. https://doi.org/10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B
  103. Falini B, Fizzotti M, Pucciarini A, et al (2000). A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood, 95, 2084-92.
  104. Fatima SS, Minhas K, Din NU, et al (2013). Sinonasal teratocarcinosarcoma: a clinicopathologic and immunohistochemical study of 6 cases. Ann Diagn Pathol, 17, 313-8. https://doi.org/10.1016/j.anndiagpath.2013.01.003
  105. Fatima S, Ahmad Z, Azam M (2010). Benign metastasizing leiomyoma: a case report. IJPM, 53, 802-4.
  106. Ficarra V, Martignoni G, Maffei N, et al (2005). Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer, 103, 68-75. https://doi.org/10.1002/cncr.20749
  107. Figarella-Branger D, Pellissier JF, Daumas-Duport C et al (1992). Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol, 16, 97-109. https://doi.org/10.1097/00000478-199202000-00001
  108. Figarelle-Branger D, Sylemezoglu, Burger PC (2007). Central Neurocytoma and extraventricular neurocytoma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th Edition, Lyon, 106-9.
  109. Fletcher CD, Berman JJ, Corless C, et al (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol, 10, 81-9. https://doi.org/10.1177/106689690201000201
  110. Fletcher CDM, Chibon F, Mertens F (2013). Undifferentiated/unclassified sarcomas. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertons F eds. WHO classification of Tumors of Soft Tissue and Bone. 4th edition, IARC, Lyon, 236-8.
  111. Folpe AL, Hornick JL, Mertens F (2013). Low-grade fibromyxoid sarcoma. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F eds: WHO Classification of Tumors of Soft tissue and bone. 4th edition, IARC, Lyon, 95-6.
  112. Foschini MP, Scarpellini F, Gown AM, et al (2000). Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol, 8, 29-37. https://doi.org/10.1177/106689690000800108
  113. Foss HD, Reusch R, Demel G, et al (1999). Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood, 94, 3108-13.
  114. Foulkes WD, Smith IE, Reis-Filho JS (2010). Triple-negative breast cancer. N Engl J Med, 363, 1938-48. https://doi.org/10.1056/NEJMra1001389
  115. Freedland SJ, Aronson WJ, Terris MK, et al (2003). Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol, 169, 2136-41. https://doi.org/10.1097/01.ju.0000065588.82511.06
  116. Freedland SJ, Csathy GS, Dorey F, et al (2002). Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol, 167, 516-20. https://doi.org/10.1016/S0022-5347(01)69076-1
  117. Fuhrman SA, Lasky LC, Limas C (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6, 655-63. https://doi.org/10.1097/00000478-198210000-00007
  118. Galea MH, Blamey RW, Elston CE, et al (1992). The nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat, 22, 207-19. https://doi.org/10.1007/BF01840834
  119. Gatalica Z, Kovatich A, Miettinea M (1995). Consistent expression of cytokeratin 7 in papillary renal-cell carcinoma. An immunohistochemical study in formalin fixed, paraffin embedded tissues. J Urol Pathol, 3, 205-11.
  120. Gephardt GN, Zarbo RJ (1997). Interinstitutional comparison of frozen section consultations. A college of American Pathologists Q-Probes study of 90, 538 cases in 461 institutions. Arch Pathol Lab Med, 120, 804-9.
  121. Gianni C, Rushing EJ, Hainfelluer JA (2007). Haemangiopericytoma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th Edition, Lyon, 178-80.
  122. Giannini C, Burger PC, Berkey BA, et al (2008). Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol, 18, 360-9. https://doi.org/10.1111/j.1750-3639.2008.00129.x
  123. Gilks CB, Young RH, Aguirre P, et al (1989). Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol, 13, 717-29. https://doi.org/10.1097/00000478-198909000-00001
  124. Gitsch G, Friedlander ML, Wain GV, et al (1995). Uterine papillary serous carcinoma. A clinical study. Cancer, 75, 2239-43. https://doi.org/10.1002/1097-0142(19950501)75:9<2239::AID-CNCR2820750908>3.0.CO;2-7
  125. Gleason DF (1992). Histologic grading of prostate cancer: a perspective. Hum Pathol, 23, 273-9. https://doi.org/10.1016/0046-8177(92)90108-F
  126. Gleason DF, Mellinger GT (1974). Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111, 58-64. https://doi.org/10.1016/S0022-5347(17)59889-4
  127. Gondos B, Migliozzi JA (1987). Intratubular germ cell neoplasia. Semin Diagn Pathol, 4, 292-303.
  128. Gopalan A, Dhall D, Olgac S, et al (2009). Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol, 22, 1066-74. https://doi.org/10.1038/modpathol.2009.66
  129. Grabsch H, Sivakumar S, Gray S, et al (2010). HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series. Cell Oncol, 32, 57-65.
  130. Green FL, Page DL, Fleming ID, et al (2002). AJCC Cancer Staginig Manual 6th Edition, Springer, New York.
  131. Gubler MC (2008). Inherited diseases of the glomerular basement membrane. Nat Clin Pract Nephrol, 4, 24-37. https://doi.org/10.1038/ncpneph0671
  132. Gupta R, Webb-Myers R, Flanagan S, et al (2011). Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications. J Clin Pathol, 64, 835-44. https://doi.org/10.1136/jclinpath-2011-200227
  133. Haberler C, Laggner U, Slavc I, et al (2006). Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol, 30, 1462-8. https://doi.org/10.1097/01.pas.0000213329.71745.ef
  134. Haralambieva E, Pulford KA, Lamant L, et al (2000). Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol, 109, 584-91. https://doi.org/10.1046/j.1365-2141.2000.02045.x
  135. Harris L, Fritsche H, Mennel R, et al (2007). American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 25, 5287-312. https://doi.org/10.1200/JCO.2007.14.2364
  136. Harris NL, Jaffe ES, Stein H, et al (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-92.
  137. Heintz AP, Odicino F, Maisonneuve P, et al (2001). Carcinoma of the ovary. J Epidemiol Biostat, 6, 107-38.
  138. Hicks DG, Kulkarni S (2008). HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol, 129, 263-73. https://doi.org/10.1309/99AE032R9FM8WND1
  139. Hirsch HH (2005). BK virus: opportunity makes a pathogen. Clin Infect Dis, 41, 354-60. https://doi.org/10.1086/431488
  140. Hirsch HH, Knowles W, Dickenmann M, et al (2002). Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med, 347, 488-96. https://doi.org/10.1056/NEJMoa020439
  141. Hoon V, Thung SN, Kaneko M, et al (1994). HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med, 118, 732-4.
  142. Hornick JL, Fletcher CD (2004). The significance of KIT (CD117) in gastrointestinal stromal tumors. Int J Surg Pathol, 12, 93-7. https://doi.org/10.1177/106689690401200201
  143. Horsman DE, Gascoyne RD, Coupland RW, et al (1995). Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol, 103, 472-8. https://doi.org/10.1093/ajcp/103.4.472
  144. Howanitz PJ, Hoffman GG, Zarbo RJ (1990). The accuracy of frozen-section diagnoses in 34 hospitals. Arch Pathol Lab Med, 114, 355-9.
  145. Huettner PC, Gersell DJ (1994). Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol, 13, 191-8. https://doi.org/10.1097/00004347-199407000-00001
  146. Ichimura K (2012). Molecular pathogenesis of IDH mutations in gliomas. Brain Tumor Pathol, 29, 131-9. https://doi.org/10.1007/s10014-012-0090-4
  147. Inflammatory fibroid polyp (IFP) in Miettinen M, fletcher CDM, Kinddblom LG, Tsui WMS (2010). Messenchymal tumors of the small intestine. In Bosman FT, Carneiro F, Hruban RH, Theise ND eds : WHO Classification of Tumors of the Digestive System. IARC, Lyon, 115-6.
  148. Jacobsen GK, Norgaard-Pedersen B (1984). Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A, 92, 323-9.
  149. Jaffe ES, Harris NL, Stein H, et al (2001). WHO Classification of Tumors. Pathology and genetics of tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC press.
  150. Jaffe ES, Ralfkiaer (2001). Mature T-cell and NK-cell neoplasms: Introduction. In Jaffe ES, Harris NL, Stein H, Vardiman JW eds. WHO classification of tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC press, Lyon, 191-4.
  151. Johansson L (2004). Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping. Ann Diagn Pathol, 8, 259-67. https://doi.org/10.1016/j.anndiagpath.2004.07.001
  152. Johnson L, Petty CS, Neaves WB (1980). The relationship of biopsy evaluations and testicular measurements to over-all daily sperm production in human testes. Fertil Steril, 34, 36-40. https://doi.org/10.1016/S0015-0282(16)44836-3
  153. Jones D, Jorgensen JL, Shahsafaei A, et al (1998). Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol, 22, 956-64. https://doi.org/10.1097/00000478-199808000-00005
  154. Jones MW, Tavassoli FA (1995). Coexistence of nipple duct adenoma and breast carcinoma: a clinicopathologic study of five cases and review of the literature. Mod Pathol, 8, 633-6.
  155. Jorgensen JT (2010). Targeted HER2 treatment in advanced gastric cancer. Oncology, 78, 26-33. https://doi.org/10.1159/000288295
  156. Judkins AR, Eberhart CG, Wesseling P (2007). Atypical teratoid/rhabdoid tumor. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th Edition, Lyon, 147-9.
  157. Jung SM, Kuo TT (2005). Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol, 18, 788-94. https://doi.org/10.1038/modpathol.3800351
  158. Kaku T, Silverberg SG, Major FJ, et al (1992). Adenosarcoma of the uterus: a gynecologic oncology group clinicopathologic study of 31 cases. Int J Gynecol Pathol, 11, 75-88. https://doi.org/10.1097/00004347-199204000-00001
  159. Kanzler MH (2010). Sentinel node biopsy and standard of care for melanoma: a re-evaluation of the evidence. J Am Acad Dermatol, 62, 880-4. https://doi.org/10.1016/j.jaad.2009.08.063
  160. Katoh R, Miyagi E, Nakamura N, et al (2000). Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. Hum Pathol, 31, 386-93. https://doi.org/10.1016/S0046-8177(00)80255-5
  161. Kim JJ, Wright TC, Goldie SJ (2002). Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA, 287, 2382-90. https://doi.org/10.1001/jama.287.18.2382
  162. Kim YS, Kim SH, Cho J, et al (2012). MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. Int J Radiat Oncol Biol Phys, 84, 661-7. https://doi.org/10.1016/j.ijrobp.2011.12.086
  163. Kinney MC, Greer JP, Glick AD, et al (1991). Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications. Pathol Annu, 26, 1-24.
  164. Kleihues P, Burger PC, Aldape KD, et al (2007). Gliosarcoma. In Glioblastoma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th Edition, Lyon, 33-49.
  165. Kleihues P, Sobin LH (2000). World Health Organization classification of tumors. Cancer, 88, 2887. https://doi.org/10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F
  166. Koerner F (2010). Papilloma and papillary carcinoma. Semin Diagn Pathol, 27, 13-30. https://doi.org/10.1053/j.semdp.2009.12.004
  167. Kros JM, Gorlia T, Kouwenhoven MC, et al (2007). Panel review of anaplastic oligodendroglioma from European organization for research and treatment of cancer trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol, 66, 545-51. https://doi.org/10.1097/01.jnen.0000263869.84188.72
  168. Kryvenko ON, Diaz M, Meier FA, et al (2012). Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs. Am J Clin Pathol, 137, 739-46. https://doi.org/10.1309/AJCPWIZ9X2DMBEBM
  169. Kunju LP, Mehra R, Snyder M, et al (2006). Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol, 125, 675-81. https://doi.org/10.1309/V1RY91NKX5ARW2Q5
  170. Kurman RJ, Norris HJ (1986). Endometrium. In Henson DE, Alboress-Saavedraaa J (eds): The Pathology of incipient neoplasis. Philadelphia, W.B. Saunders: 2, 65-77.
  171. Kurman RJ, Shih Ie M (2010). The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol, 34, 433-43. https://doi.org/10.1097/PAS.0b013e3181cf3d79
  172. Kurman RJ, Solomon D (1994). the Bethesda System for reporting cervical/Vaginal Cytologic Diagnoses. New York: Springer-verlog.
  173. Ladanyi M, Antonescu CR, Leung DH, et al (2002). Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res, 62, 135-40.
  174. Lai R, Arber DA, Chang KL, et al (1998). Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol, 11, 864-9.
  175. Lakhani SR, Ellis IO, Schnitt SJ, et al (2012). World Health Organization classification of Tumors of the Breast, Fourth edition, IARC, Press, Lyon.
  176. Lamont JM, McManamy CS, Pearson AD, et al (2004). Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res, 10, 5482-93. https://doi.org/10.1158/1078-0432.CCR-03-0721
  177. Lang H, Lindner V, de Fromont M, et al (2005). Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with >15-year follow-up. Cancer, 103, 625-9. https://doi.org/10.1002/cncr.20812
  178. LaRusso NF, Shneider BL, Black D, et al (2006). Primary sclerosing cholangitis: summary of a workshop. Hepatology, 44, 746-64. https://doi.org/10.1002/hep.21337
  179. Lau SK, Luthringer DJ, Eisen RN (2002). Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol, 10, 97-102.
  180. Leoncini L, Raphael M, Stein H, et al (2008). Burkitt Lymphoma. In Swerdlow SH, Campo E, Harris NL, Satte ES, Pileri SA, Stein H, et al. WHO classification of tumors of Hematopoitic and lymphoid tissues. 4th edition, IARC, Lyon, 262-4.
  181. Lerwill MF (2008). Flat epithelial atypia of the breast. Arch Pathol Lab Med, 132, 615-21.
  182. Li JY, Gaillard F, Moreau A, et al (1999). Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol, 154, 1449-52. https://doi.org/10.1016/S0002-9440(10)65399-0
  183. Liebowitz D (1994). Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol, 21, 376-81.
  184. Lin P, Owens R, Tricot G, et al (2004). Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J clin Pathol, 121, 482-8. https://doi.org/10.1309/74R4TB90BUWH27JX
  185. Livolsi VA (2010). Papillary carcinoma tall cell variant (TCV): a review. Endocr Pathol, 21, 12-5. https://doi.org/10.1007/s12022-010-9106-y
  186. Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
  187. Loy TS, Phillips RW, Linder CL (2002). A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases. Arch Pathol Lab Med, 126, 170-2.
  188. Loy V, Dieckmann KP (1990). Carcinoma in situ of the testis: intratubular germ cell neoplasia or testicular intraepithelial neoplasia? Hum Pathol, 21, 457-8.
  189. Ludwig J, Viggiano TR, McGill DB, et al (1980). Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, 55, 434-8.
  190. Mangini J, Li N, Bhawan J (2002). Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am J Dermatopathol, 24, 270-81. https://doi.org/10.1097/00000372-200206000-00016
  191. Maris JM, Matthay KK (1999). Molecular biology of neuroblastoma. J Clin Oncol, 17, 2264-79. https://doi.org/10.1200/JCO.1999.17.7.2264
  192. Mauiyyedi S, Crespo M, Collins AB, et al (2002). Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol, 13, 779-87.
  193. McCluggage WG (2011). Benign diseases of the endometrium. In Kurman RJ, Ellenson LH, Ronnett BM eds: Blaustein's Pathology of the female genital tract. Sixth edition: Springer, 305-58.
  194. McCluggage WG, Maxwell P, Sloan JM (1997). Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol, 28, 1034-8. https://doi.org/10.1016/S0046-8177(97)90056-3
  195. McCluggage WG, Sumathi VP, Maxwell P (2001). CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology, 39, 273-8. https://doi.org/10.1046/j.1365-2559.2001.01215.x
  196. Mckenna RW, Kyle RA, Kuehl WM, et al (2008). Plasma cell neoplasms. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 200-13.
  197. Memon A, Ahmad Z, Qureshi A, et al (2009). Staging of prostatic adenocarcinoma with radical prostatectomy specimens in Pakistan. Asian Pac J Cancer Prev, 10, 551-4.
  198. Mentzel T, Beham A, Katenkamp D, et al (1998). Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol, 22, 576-87. https://doi.org/10.1097/00000478-199805000-00009
  199. Mentzel T, Hogendoorn PCW, Huang H-Y (2013). Myxofibrosarcoma. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F eds: WHO Classification of Tumors of Soft tissue and bone. 4th edition, IARC, Lyon, 93-4.
  200. Miettinen M, Fanburg-Smith JC, Virolainen M, et al (1999). Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol, 30, 934-42. https://doi.org/10.1016/S0046-8177(99)90247-2
  201. Miettinen M, Lasota J (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol, 23, 70-83. https://doi.org/10.1053/j.semdp.2006.09.001
  202. Miettinen M, Limon J, Niezabitowski A, et al (2000). Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch, 437, 275-83. https://doi.org/10.1007/s004280000238
  203. Miettinen M, Lindenmayer AE, Chaubal A (1994). Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol, 7, 82-90.
  204. Miettinen M, Sobin LH, Sarlomo-Rikala M (2000). Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol, 13, 1134-42. https://doi.org/10.1038/modpathol.3880210
  205. Miettinen M, Wang ZF, Lasota J (2009). DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol, 33, 1401-8. https://doi.org/10.1097/PAS.0b013e3181a90e1a
  206. Mikuta JJ (1993). International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer, 71, 1460-3. https://doi.org/10.1002/cncr.2820710409
  207. Mills SE, Austin MB, Randall ME (1985). Lymphoepithelioma-like carcinoma of the uterine cervix. A distinctive, undifferentiated carcinoma with inflammatory stroma. Am J Surg Pathol, 9, 883-9. https://doi.org/10.1097/00000478-198512000-00004
  208. Mok TS, Wu YL, Thongprasert S, et al (2009). Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med, 361, 947-57. https://doi.org/10.1056/NEJMoa0810699
  209. Morken NH, Henriksen H (2001). Placenta percreta--two cases and review of the literature. Eur J Obstet Gynecol Reprod Biol, 100, 112-5. https://doi.org/10.1016/S0301-2115(01)00422-5
  210. Morotti RA, Nicol KK, Parham DM, et al (2006). An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am J Surg Pathol, 30, 962-8. https://doi.org/10.1097/00000478-200608000-00005
  211. Mostofi FK (1960). Standardization of nomenclature and criteria for diagnosis of epithelial tumor of urinary bladder. Acta Unia Int Contra Cancer, 16, 310-4.
  212. Mutter GL, Nogales F, Kurman R, et al (2002). Endometrial cancer. In Tavassoli FA, Stratton MR (eds): WHO classification of tumors: pathology and genetics. Tumors of the Breast and female genital organs. Lyon, IARC press.
  213. Nadji M, Tabei SZ, Castro A et al (1981). Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer, 48, 1229-32. https://doi.org/10.1002/1097-0142(19810901)48:5<1229::AID-CNCR2820480529>3.0.CO;2-L
  214. Nasr MR, Mukhopadhyay S, Zhang S, et al (2006). Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining. Mod Pathol, 19, 1631-7. https://doi.org/10.1038/modpathol.3800705
  215. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage (1982). The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer, 49, 2112-35. https://doi.org/10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2
  216. National Cancer Institute Workshop (1988). The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnosis. JAMA, 262, 931-2.
  217. Nielsen GP, O'Connell JX, Dickersin GR, Rosenberg AE (1997). Solitary fibrous tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol, 10, 1028-37.
  218. No authors listed (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group (2000). Br J Cancer, 83, 1301-8. https://doi.org/10.1054/bjoc.2000.1407
  219. Norris HJ, Taylor HB (1966). Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer, 19, 755-66. https://doi.org/10.1002/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U
  220. Northcott PA, Korshunov A, Witt H, et al (2011). Medulloblastoma comprises four distinct molecular variants. J Clin Oncol, 29, 1408-14. https://doi.org/10.1200/JCO.2009.27.4324
  221. Novis DA, Zarbo RJ (1997). Interinstitutional comparison of frozen section turnaround time. A College of American Pathologists Q-Probes study of 32868 frozen sections in 700 hospitals. Arch Pathol Lab Med, 121, 559-67.
  222. Oates J, Edwards C (2000). HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology, 36, 341-7. https://doi.org/10.1046/j.1365-2559.2000.00770.x
  223. Ockner DM, Sayadi H, Swanson PE, et al (1997). Genital angiomyofibroblastoma. Comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue. Am J Clin Pathol, 107, 36-44. https://doi.org/10.1093/ajcp/107.1.36
  224. O'Connell FP, Pinkus JL, Pinkus GS (2004). CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol, 121, 254-63. https://doi.org/10.1309/617DWB5GNFWXHW4L
  225. Okada N, Hasebe T, Iwasaki M, et al (2010). Metaplastic carcinoma of the breast. Hum Pathol, 41, 960-70. https://doi.org/10.1016/j.humpath.2009.11.013
  226. Olsen SH, Thomas DG, Lucas DR (2006). Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol, 19, 659-68. https://doi.org/10.1038/modpathol.3800569
  227. Oppedal BR, Brandtzaeg P, Kemshead JT (1987). Immunohistochemical differentiation of neuroblastomas from other small round cell neoplasms of childhood using a panel of mono- and polyclonal antibodies. Histopathology, 11, 363-74. https://doi.org/10.1111/j.1365-2559.1987.tb02641.x
  228. Ordonez NG (2005). Immunohistochemical diagnosis of epitheloid mesothelioma: an update. Arch Pathol Lab Med, 129, 407-14.
  229. Osborn M, Dirk T, Kaser H, et al (1986). Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma. Am J Pathol, 122, 433-42.
  230. Pai RK, Beck AH, Norton JA, et al (2009). Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol, 33, 1425-39. https://doi.org/10.1097/PAS.0b013e3181af6067
  231. Papouchado BG, Myles J, Lloyd RV, et al (2010). Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility. Am J Surg Pathol, 34, 767-76. https://doi.org/10.1097/PAS.0b013e3181d96231
  232. Pecorelli S, Odicino F (2003). Cervical cancer staging. Cancer J, 9, 390-4. https://doi.org/10.1097/00130404-200309000-00009
  233. Perry A, Louis DN, Scheithauer BEW, et al (2007). Meningiomas. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th Edition, Lyon, 164-72.
  234. Perry A, Scheithauer BW, Nascimento AG (1997). The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol, 21, 1354-60. https://doi.org/10.1097/00000478-199711000-00010
  235. Pirker R, Herth FJ, Kerr KM, et al (2010). Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol, 5, 1706-13. https://doi.org/10.1097/JTO.0b013e3181f1c8de
  236. Poppema S, Delsol G, Pileri SA, et al (2008). Nodular lymphocyte predominant Hodgkin lymphoma. In Swerdlow SH, Campo E, Harris NL, Satte ES, Pileri SA, Stein H, et al. WHO classification of tumors of Hematopoitic and lymphoid tissues. 4th edition, IARC, Lyon, 323-5.
  237. Prey MU (2004). Computer assisted interpretation of cervical cytology. In Solomon D, Nayar R eds: The Bethesda System for reporting Cervical Cytology. Second edition. Springer, New York, 181-4.
  238. Rakha EA, El-Sheikh SE, Kandil MA, et al (2008). Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol, 39, 857-65. https://doi.org/10.1016/j.humpath.2007.10.011
  239. Rassenti LZ, Huynh L, Toy TL, et al (2004). ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med, 351, 893-901. https://doi.org/10.1056/NEJMoa040857
  240. Raza A, Ahmad Z, Muzzaffar S (2006). Placental site trophoblastic tumor (PSTT) with metastases to lungs and adrenal glands. J Coll Physicians Surg Pak, 16, 150-1.
  241. Reis-Filho JS, Tutt AN (2008). Triple negative tumours: a critical review. Histopathology, 52, 108-18.
  242. Reporting on Cancer Specimens Case summaries and Background Documentaion. College of American Pathologists (CAP). CAP press, 2012.
  243. Rhodes A, Jasani B, Anderson E, et al (2002). Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol, 118, 408-17. https://doi.org/10.1309/97WN-W6UX-XJWT-02H2
  244. Richart RM (1973). Cervical intraepithelial neoplasia. Pathol Annu, 8, 301-28.
  245. Rindi G, Kloppel G, Alhman H, et al (2006). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 449, 395-401. https://doi.org/10.1007/s00428-006-0250-1
  246. Robson M, Offit K (2007). Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med, 357, 154-62. https://doi.org/10.1056/NEJMcp071286
  247. Robson M, Svahn T, McCormick B, et al (2005). Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer, 103, 44-51. https://doi.org/10.1002/cncr.20728
  248. Roma AA, Magi-Galluzzi C, Zhou M (2007). Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab Med, 131, 122-5.
  249. Ronnett BM, Kurman RJ, Zahn CM, et al (1995). Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol, 26, 509-24. https://doi.org/10.1016/0046-8177(95)90247-3
  250. Rosai J (2008). The benign versus malignant paradigm in oncologic pathology: a critique. Semin Diagn Pathol, 25, 147-53. https://doi.org/10.1053/j.semdp.2008.07.002
  251. Rosen PP, Caicco JA (1986). Florid papillomatosis of the nipple. A study of 51 patients, including nine with mammary carcinoma. Am J Surg Pathol, 10, 87-101. https://doi.org/10.1097/00000478-198602000-00002
  252. Sadighi Z, Vats T, Khatua S (2012). Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile. J Child Neurol, 27, 1302-7. https://doi.org/10.1177/0883073812449690
  253. Scheuer PJ (1991). Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 13, 372-4. https://doi.org/10.1016/0168-8278(91)90084-O
  254. Schmid KW, Dockhorn-Dworniczak B, Fahrenkamp A, et al (1993). Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. Histopathology, 22, 527-33. https://doi.org/10.1111/j.1365-2559.1993.tb00172.x
  255. Schmid KW, Kirchmair R, Ladurner D, et al (1992). Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid. Histopathology, 21, 225-32. https://doi.org/10.1111/j.1365-2559.1992.tb00380.x
  256. Schmidt MC, Antweiler S, Urban N, et al (2002). Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol, 61, 321-8. https://doi.org/10.1093/jnen/61.4.321
  257. Schwartz GF, Giuliano AE, Veronesi U (2002). Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol, 33, 579-89. https://doi.org/10.1053/hupa.2002.124117
  258. Sebo TJ, Bock BJ, Cheville JC, et al (2000). The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol, 163, 174-8. https://doi.org/10.1016/S0022-5347(05)67998-0
  259. Seidman JD, Elsayed AM, Sobin LH, et al (1993). Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol, 17, 22-34. https://doi.org/10.1097/00000478-199301000-00003
  260. Sever M, Jones TD, Roth LM, et al (2005). Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Mod Pathol, 18, 1411-6. https://doi.org/10.1038/modpathol.3800463
  261. Sevin BU, Nadji M, Averette HE, et al (1992). Microinvasive carcinoma of the cervix. Cancer, 70, 2121-8. https://doi.org/10.1002/1097-0142(19921015)70:8<2121::AID-CNCR2820700819>3.0.CO;2-S
  262. Shah RB (2009). Current perspectives on the Gleason grading of prostate cancer. Arch Pathol Lab Med, 133, 1810-6.
  263. Shah RB, Zhou M, LeBlanc M, et al (2002). Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol, 26, 1161-8. https://doi.org/10.1097/00000478-200209000-00006
  264. Shimada H, Ambros IM, Dehner LP, et al (1999). Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer, 86, 349-63. https://doi.org/10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y
  265. Shimada H, Ambros IM, Dehner LP, et al (1999). The International Neuroblastoma Pathology Classification (the Shimada system). Cancer, 86, 364-72. https://doi.org/10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7
  266. Shimada H, Chatten J, Newton WA, et al (1984). Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst, 73, 405-16. https://doi.org/10.1093/jnci/73.2.405
  267. Silini EM, Bosi F, Pellegata NS, et al (1994). K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma. Virchows Arch, 424, 367-73.
  268. Silverberg SG (2002). Sentinel node processing: recommendations for pathologists. Am J Surg Pathol, 26, 383-5. https://doi.org/10.1097/00000478-200203000-00014
  269. Snover DC, Ahnen DJ, Burt AW, et al (2010). Serrated polyps of the colon and rectum and serrated polyposis. In Bosman FT, Carneiro F, Hruban RH, Theise ND eds: WHO Classification of Tumors of the Digestive System. IARC, Lyon, 160-5.
  270. Sokol RJ, Shepherd RW, Superina R, et al (2007). Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology, 46, 566-81. https://doi.org/10.1002/hep.21790
  271. Solcia E, Kloppel G, Sobin LH eds (2000). World Health Organization International Histological Classification of Tumors. 2nd ed. New York, NY: Springer.
  272. Solomon D, Davey DD, Kurman R, et al (2002).The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9. https://doi.org/10.1001/jama.287.16.2114
  273. Solomon D, Nayar R (2004): The Bethesda System for reporting of Cervical Cytology. Definitions, Criteria and Explanatory Notes. Second edition, Springer, New York.
  274. Soylemezoglu F, Onder S, Tezel GG, et al (2003). Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract, 199, 463-8. https://doi.org/10.1078/0344-0338-00446
  275. Spina D, Leoncini L, Megha T, et al (1997). Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. J Pathol, 182, 145-50. https://doi.org/10.1002/(SICI)1096-9896(199706)182:2<145::AID-PATH819>3.0.CO;2-P
  276. Swerdlow SH, Campo E, Harris NL, et al (2008). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Ed 4. Lyon, IARC press.
  277. Swerdlow SH, Webber SA, Chadburn A, et al (2008). Post-transplant lymphoproliferative disorders. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 343-9.
  278. Swerdlow SH, Yang WI, Zukerberg LR, et al (1995). Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol, 26, 999-1004. https://doi.org/10.1016/0046-8177(95)90090-X
  279. Talley NJ, Shorter RG, Phillips SF, et al (1990). Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut, 31, 54-8. https://doi.org/10.1136/gut.31.1.54
  280. Tan BT, Warnke RA, Arber DA (2006). The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn, 8, 466-75. https://doi.org/10.2353/jmoldx.2006.060016
  281. Tan DS, Marchio C, Reis-Filho JS (2008). Hereditary breast cancer: from molecular pathology to tailored therapies. J Clin Pathol, 61, 1073-82. https://doi.org/10.1136/jcp.2008.057950
  282. The ALTS Group (2003). Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 188, 1383-92. https://doi.org/10.1016/S0002-9378(03)00418-6
  283. Travis WD, Brambilla E, Muller-Hermelink HK, et al (2004). World Health Organization classification of tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. IARC, Press, Lyon.
  284. Trojani M, Contesso G, Coindre JM, et al (1984). Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer, 33, 37-42. https://doi.org/10.1002/ijc.2910330108
  285. Turc-Carel C, Aurias A, Mugneret F, et al (1988). Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet, 32, 229-38. https://doi.org/10.1016/0165-4608(88)90285-3
  286. Ud Din N, Memon A, Aftab K, et al (2012). Oligodendroglioma arising in the glial component of ovarian teratomas: a series of six cases and review of literature. J Clin Pathol, 65, 631-4. https://doi.org/10.1136/jclinpath-2012-200714
  287. Ud Din N, Memon A, Idress R, et al (2011). Central nervous system lesions: correlation of intraoperative and final diagnoses, six year experience at a referral centre in a developing country, Pakistan. Asian Pac J Cancer Prev, 12, 1435-7.
  288. Ueng SH, Mezzetti T, Tavassoli FA (2009). Papillary neoplasms of the breast: a review. Arch Pathol Lab Med, 133, 893-907.
  289. Union for International Cancer Control (UICC): TNM classification of malignant tumors 7th ed. Sobin LH, Gospodarowiez MK, Wittekind CH eds (2010). Wiley-Blackwell, Oxford.
  290. Vallat-Decouvelare, Wassef M, Lot G (1999). Spinal melanotic schwannoma: a tumor with poor prognosis. Histopathology, 35, 558-66. https://doi.org/10.1046/j.1365-2559.1999.00786.x
  291. Varela-Duran J, Enzinger EM (1982). Calcifying synovial sarcoma. Cancer, 50, 345-52. https://doi.org/10.1002/1097-0142(19820715)50:2<345::AID-CNCR2820500231>3.0.CO;2-Y
  292. Varma M, Morgan M, Jasani B, et al (2002). Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Am J Clin Pathol, 118, 202-7. https://doi.org/10.1309/BGWQ-P26T-7TR6-VGT3
  293. Vasel M, Moch H, Mousavi A, et al (2008). Immunohistochemical profiling of Wilm's tumor: a tissue microarray study. Appl Immunohistochem Mol Morphol, 16, 128-34. https://doi.org/10.1097/PAI.0b013e31804d6825
  294. Vuitch MF, Rosen PP, Erlandson RA (1986). Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol, 17, 185-91. https://doi.org/10.1016/S0046-8177(86)80292-1
  295. Wagoner J, Keehn C, Morgan MB (2007). CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma. Am J Dermatopathol, 29, 555-8. https://doi.org/10.1097/DAD.0b013e3181596978
  296. Walsh PC (1994). Radical prostatectomy: a procedure in evolution. Semin Oncol, 21, 662-71.
  297. Wang Y, Li S, Chen L, et al (2012). Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. Neuro Oncol, 14, 518-25. https://doi.org/10.1093/neuonc/nor232
  298. Warren BF, Edwards CM, Travis SP (2002). 'Microscopic colitis': classification and terminology. Histopathology, 40, 374-6. https://doi.org/10.1046/j.1365-2559.2002.01341.x
  299. Weening JJ, D'Agati VD, Schwartz MM, et al (2004). The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol, 15, 241-50. https://doi.org/10.1097/01.ASN.0000108969.21691.5D
  300. Weiss LM (1984). Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol, 8, 163-9. https://doi.org/10.1097/00000478-198403000-00001
  301. Weiss LM, Medeiros LJ, Vickery AL (1989). Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol, 13, 202-6. https://doi.org/10.1097/00000478-198903000-00004
  302. WHO classification of tumors of bone. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F eds (2013): WHO Classification of Tumors of Soft tissue and bone. 4th edition, IARC, Lyon, 240-1.
  303. WHO classification of Tumors of Soft tissue. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013). WHO classification of tumors of soft tissue and bone. IARC, Lyon.
  304. WHO Histological Classification of Testis Tumors. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004). Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. IARC press, Lyon, 218.
  305. WHO Histological Classification of Tumors of the Kidney. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004). WHO Classification of Tumors. Tumors of the urinary System and Male Genital Organs. IARC press, Lyon.
  306. WHO Histological Classification of tumors of the ovary. In Tavasoli FA, Devilee P (2003). World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of the Breast and Female Genital Organs. IARC press, Lyon.
  307. WHO Histological Classification of Tumors of the urinary tract. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004). Pathology and Genetics of Tumors of the urinary System and Male Genital Organs. IARC press, Lyon, 90.
  308. Wick MR, Cherwitz DL, McGlennen RC, et al (1986). Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol, 122, 343-52.
  309. Williams ED (2000). Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol, 8, 181-3. https://doi.org/10.1177/106689690000800304
  310. Wirnsberger GH, Becker H, Ziervogel K, et al (1992). Diagnostic immunohistochemistry of neuroblastic tumors. Am J Surg Pathol, 16, 49-57.
  311. Wolf RE, Enneking WF (1996). The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am, 27, 473-81.
  312. Wolff AC, Hammond ME, Schwartz JN, et al (2007). American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol, 25, 118-45.
  313. Xing M, Westra WH, Tufano RP, et al (2005). BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab, 90, 6373-9. https://doi.org/10.1210/jc.2005-0987
  314. Yamaguchi R, Horii R, Maeda I, et al (2010). Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol, 41, 679-85. https://doi.org/10.1016/j.humpath.2009.10.009
  315. Yan H, Parsons DW, Jin G, et al (2009). IDH1 and IDH2 mutations in gliomas. N Engl J Med, 360, 765-73. https://doi.org/10.1056/NEJMoa0808710
  316. Yatabe Y, Mitsudomi T, Takahashi T (2002). TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol, 26, 767-73. https://doi.org/10.1097/00000478-200206000-00010
  317. Yaziji H, Gown AM (2003). Immunohistochemical markers of melanocytic tumors. Int J Surg Pathol, 11, 11-5. https://doi.org/10.1177/106689690301100103
  318. Young RH, Dickersin GR, Scully RE (1984). Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol, 8, 575-96. https://doi.org/10.1097/00000478-198408000-00002
  319. Young RH, Scully RE (1984). Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol, 27, 248-58. https://doi.org/10.1097/00003081-198403000-00032
  320. Zaino RJ (2009). FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol, 28, 1-9. https://doi.org/10.1097/PGP.0b013e3181846c6d
  321. Zhang K, Wang XQ, Zhou B, et al (2013). The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis. Fam Cancer, 12, 449-58. https://doi.org/10.1007/s10689-013-9607-1
  322. Zubair A, Qureshi A, Azam M, et al (2010). Epidemiological data for common bone sarcomas. Asian Pac J Cancer Prev, 11, 393-5.
  323. Zucca E, Stein H, Coiffier B (1994). European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL). Ann Oncol, 5, 507-11. https://doi.org/10.1093/oxfordjournals.annonc.a058904

피인용 문헌

  1. Errors in Surgical Pathology Reports: a Study from a Major Center in Pakistan vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1869